Thermo Fisher Completes Acquisition of Finesse Solutions
Thermo Fisher Scientific today completed its previously announced acquisition of Finesse Solutions, a developmer of scalable control automation systems and software for bioproduction. The business will be integrated into Thermo Fisher’s Life Sciences Solutions Segment. Terms of the transaction were not disclosed.
Based in Santa Clara, California, Finesse Solutions is a bioprocess management technology, generating approximately $50 million in revenue in 2016. Its proprietary Smart™ technology, which consists of sensors, controllers and software, is designed to optimize the bioproduction workflow. The company has been a technology partner of Thermo Fisher Scientific since 2013.
This article has been republished from materials provided by Thermo Fisher. Note: material may have been edited for length and content. For further information, please contact the cited source.
A team of researchers has now created 3D maps of MT1 and MT2 melatonin receptors revealing the structural basis of the selectivity of each receptor subtype. They intend to use this structural information to design drug molecules that better target and bind to each of the two receptors.READ MORE